# Continuing Treatment With Pegasys and Copegus

> **NCT00336518** · PHASE3 · UNKNOWN · sponsor: **Májbetegekért Alapítvány** · enrollment: 100 (—)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** peginterferon alfa-2a
- **DRUG:** ribavirin

## Key facts

- **NCT ID:** NCT00336518
- **Lead sponsor:** Májbetegekért Alapítvány
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** 2009-07
- **Target enrollment:** 100 (—)
- **Last updated:** 2006-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00336518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00336518, "Continuing Treatment With Pegasys and Copegus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00336518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*